spacer
spacer
Go to PDB code: 
protein Protein-protein interface(s) links
Ligase PDB id
1i7k
Jmol
Contents
Protein chains
146 a.a. *
Waters ×196
* Residue conservation analysis
PDB id:
1i7k
Name: Ligase
Title: Crystal structure of human mitotic-specific ubiquitin- conjugating enzyme, ubch10
Structure: Ubiquitin-conjugating enzyme e2 h10. Chain: a, b. Synonym: ubiquitin-conjugating enzyme ubch10. Engineered: yes. Mutation: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: ubch10. Expressed in: escherichia coli. Expression_system_taxid: 562.
Resolution:
1.95Å     R-factor:   0.176     R-free:   0.226
Authors: R.Basavappa,Y.Lin
Key ref:
Y.Lin et al. (2002). Structural and functional analysis of the human mitotic-specific ubiquitin-conjugating enzyme, UbcH10. J Biol Chem, 277, 21913-21921. PubMed id: 11927573 DOI: 10.1074/jbc.M109398200
Date:
09-Mar-01     Release date:   04-Apr-01    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
O00762  (UBE2C_HUMAN) -  Ubiquitin-conjugating enzyme E2 C
Seq:
Struc:
179 a.a.
146 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 1 residue position (black cross)

 Enzyme reactions 
   Enzyme class: E.C.6.3.2.19  - Ubiquitin--protein ligase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: ATP + ubiquitin + protein lysine = AMP + diphosphate + protein N-ubiquityllysine
ATP
+ ubiquitin
+ protein lysine
= AMP
+ diphosphate
+ protein N-ubiquityllysine
Molecule diagrams generated from .mol files obtained from the KEGG ftp site
 Gene Ontology (GO) functional annotation 
  GO annot!
  Cellular component     cytosol   3 terms 
  Biological process     cell cycle   19 terms 
  Biochemical function     nucleotide binding     6 terms  

 

 
    reference    
 
 
DOI no: 10.1074/jbc.M109398200 J Biol Chem 277:21913-21921 (2002)
PubMed id: 11927573  
 
 
Structural and functional analysis of the human mitotic-specific ubiquitin-conjugating enzyme, UbcH10.
Y.Lin, W.C.Hwang, R.Basavappa.
 
  ABSTRACT  
 
Cell cycle progression is controlled at several different junctures by the targeted destruction of cell cycle regulatory proteins. These carefully orchestrated events include the destruction of the securin protein to permit entry into anaphase, and the destruction of cyclin B to permit exit from mitosis. These destruction events are mediated by the ubiquitin/proteasome system. The human ubiquitin-conjugating enzyme, UbcH10, is an essential mediator of the mitotic destruction events. We report here the 1.95-A crystal structure of a mutant UbcH10, in which the active site cysteine has been replaced with a serine. Functional analysis indicates that the mutant is active in accepting ubiquitin, although not as efficiently as wild-type. Examination of the crystal structure reveals that the NH2-terminal extension in UbcH10 is disordered and that a conserved 3(10)-helix places a lysine residue near the active site. Analysis of relevant mutants demonstrates that for ubiquitin-adduct formation the presence or absence of the NH2-terminal extension has little effect, whereas the lysine residue near the active site has significant effect. The structure provides additional insight into UbcH10 function including possible sites of interaction with the anaphase promoting complex/cyclosome and the disposition of a putative destruction box motif in the structure.
 
  Selected figure(s)  
 
Figure 5.
Fig. 5. The 3[10] helix situated near the active site (divergent stereoview). The molecular surface was calculated using all residues except those in the 3[10] helix (residues 115-119). The residues forming the 3[10] helix are shown in ball-and-stick representation. The geometry of the 3[10] helix allows the hydrophobic residues in the helix to pack primarily against non-polar interior residues, whereas the hydrophilic residues are substantially solvent exposed. The polar residue Lys119 is seen to be proximal to the active site thiol (indicated by the dark patch). The small inset -carbon trace shows the overall perspective from which the main figure was made. The 3[10] helix and active site residue are indicated by thicker segments.
Figure 7.
Fig. 7. Candidate sites of interaction with the APC/C. The relative positions of the active site ( red) and the likely site of APC11 interaction (residues Tyr91 and Ala^124) are shown in the left figure. The right figure is related to the left figure by a rotation of 180° about a vertical axis in the plane of the paper. The colored and labeled patches are residues that are conserved only among mitotic Ubcs. The color coding is as follows: red, blue, yellow, and brown correspond to acidic, basic, polar, and hydrophobic residues, respectively. Green indicates the active site cysteine.
 
  The above figures are reprinted by permission from the ASBMB: J Biol Chem (2002, 277, 21913-21921) copyright 2002.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
19557013 A.G.Eldridge, and T.O'Brien (2010).
Therapeutic strategies within the ubiquitin proteasome system.
  Cell Death Differ, 17, 4.  
21158740 D.M.Wenzel, K.E.Stoll, and R.E.Klevit (2010).
E2s: structurally economical and functionally replete.
  Biochem J, 433, 31-42.  
19657671 L.Jiang, Y.Bao, C.Luo, G.Hu, C.Huang, X.Ding, K.Sun, and Y.Lu (2010).
Knockdown of ubiquitin-conjugating enzyme E2C/UbcH10 expression by RNA interference inhibits glioma cell proliferation and enhances cell apoptosis in vitro.
  J Cancer Res Clin Oncol, 136, 211-217.  
19779934 S.Chen, Y.Chen, C.Hu, H.Jing, Y.Cao, and X.Liu (2010).
Association of clinicopathological features with UbcH10 expression in colorectal cancer.
  J Cancer Res Clin Oncol, 136, 419-426.  
19302711 T.Fujita, H.Ikeda, N.Taira, S.Hatoh, M.Naito, and H.Doihara (2009).
Overexpression of UbcH10 alternates the cell cycle profile and accelerate the tumor proliferation in colon cancer.
  BMC Cancer, 9, 87.  
19851334 Y.Ye, and M.Rape (2009).
Building ubiquitin chains: E2 enzymes at work.
  Nat Rev Mol Cell Biol, 10, 755-764.  
18485873 L.Jin, A.Williamson, S.Banerjee, I.Philipp, and M.Rape (2008).
Mechanism of ubiquitin-chain formation by the human anaphase-promoting complex.
  Cell, 133, 653-665.  
18722180 M.K.Summers, B.Pan, K.Mukhyala, and P.K.Jackson (2008).
The unique N terminus of the UbcH10 E2 enzyme controls the threshold for APC activation and enhances checkpoint regulation of the APC.
  Mol Cell, 31, 544-556.  
18833291 S.Gong, and T.L.Blundell (2008).
Discarding functional residues from the substitution table improves predictions of active sites within three-dimensional structures.
  PLoS Comput Biol, 4, e1000179.  
18698327 T.Ravid, and M.Hochstrasser (2008).
Diversity of degradation signals in the ubiquitin-proteasome system.
  Nat Rev Mol Cell Biol, 9, 679-690.  
17310239 T.Ravid, and M.Hochstrasser (2007).
Autoregulation of an E2 enzyme by ubiquitin-chain assembly on its catalytic residue.
  Nat Cell Biol, 9, 422-427.  
17217624 J.Lin, D.A.Raoof, Z.Wang, M.Y.Lin, D.G.Thomas, J.K.Greenson, T.J.Giordano, M.B.Orringer, A.C.Chang, D.G.Beer, and L.Lin (2006).
Expression and effect of inhibition of the ubiquitin-conjugating enzyme E2C on esophageal adenocarcinoma.
  Neoplasia, 8, 1062-1071.  
15062086 C.Dominguez, A.M.Bonvin, G.S.Winkler, F.M.van Schaik, H.T.Timmers, and R.Boelens (2004).
Structural model of the UbcH5B/CNOT4 complex revealed by combining NMR, mutagenesis, and docking approaches.
  Structure, 12, 633-644.
PDB code: 1ur6
15019973 T.Dandrea, H.Hellmold, C.Jonsson, B.Zhivotovsky, T.Hofer, L.Wärngård, and I.Cotgreave (2004).
The transcriptosomal response of human A549 lung cells to a hydrogen peroxide-generating system: relationship to DNA damage, cell cycle arrest, and caspase activation.
  Free Radic Biol Med, 36, 881-896.  
12531181 T.R.Pray, F.Parlati, J.Huang, B.R.Wong, D.G.Payan, M.K.Bennett, S.D.Issakani, S.Molineaux, and S.D.Demo (2002).
Cell cycle regulatory E3 ubiquitin ligases as anticancer targets.
  Drug Resist Updat, 5, 249-258.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB code is shown on the right.